Montanoa guatemalensis
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Montanoa guatemalensis |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Montanoa Guatemalensis |
| Ipni Id | 163999-2 |
| Plant Name | Montanoa Guatemalensis |
| Genus Tax Id | 166981 |
| Disease Name | Seborrhoeic dermatitis, Oesophageal/gastroduodenal disorder, Solid tumour/cancer, Pediculosis, Asthma, Myelodysplastic syndrome, Pain, unspecified, Ewing sarcoma, Bacterial infection, Bleeding disorder, Type 2 diabetes mellitus, Alzheimer disease, Acute myeloid leukaemia, Low bone mass disorder, Myocardial infarction, Glaucoma, Autoimmune disease, Mild neurocognitive disorder, Fungal infection, Diabetes mellitus, type unspecified, Unspecific substance harmful effect, Multiple sclerosis, Crohn disease, Breast cancer, Heart failure, Acute/subacute hepatic failure, Coronary thrombosis, Lung cancer, Myasthenia gravis, Substance abuse, Peroxisomal disease, Parkinsonism, Atopic eczema, Insomnia, Psoriasis, Parasitic worm infestation, Thrombocytopenia, Rheumatoid arthritis, Skin and skin-structure infection, Coagulation defect, Choreiform disorder, Muscular dystrophy, Cardiovascular disease, Dementia, Hyper-lipoproteinaemia, Indeterminate colitis, Duodenal ulcer, Angina pectoris, Synthesis disorder, Cerebral ischaemic stroke, Thrombosis, Malignant haematopoietic neoplasm, Essential hypertension, Mature T-cell lymphoma, Ischaemic/haemorrhagic stroke, Lupus erythematosus, Myeloproliferative neoplasm, Chronic arterial occlusive disease, Irritable bowel syndrome, Nutritional deficiency, Prostate cancer, COVID-19, Metabolic disorder, Colorectal cancer, Sickle-cell disorder, Nephritic syndrome, Renal cell carcinoma, Primary sclerosing cholangitis, Chronic kidney disease, Carcinosarcoma of uterus, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Zika virus disease, Osteoarthritis, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Other specified malignant neoplasms of kidney, except renal pelvis, Keratoconus, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Malignant neoplasms of thymus, Invasive carcinoma of breast, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Ebola virus disease, Malignant neoplasms of adrenal gland |
| Species Name | Montanoa guatemalensis |
| Genus Name | Montanoa |
| Species Tax Id | 166989 |
| Disease Id | EA81, DD90, 2A00-2F9Z, 1G00, CA23, 2A37, MG3Z, 2B52, 1A00-1C4Z, GA20-GA21, 5A11, 8A20, 2A60, FB83, BA41-BA43, 9C61, 4A40-4A45, 6D71, 1F29-1F2F, 5A14, NE6Z, 8A40, DD70, 2C60-2C6Y, BD10-BD1Z, DB91, BA43, 2C25, 8C6Y, 6C40, 5C57, 8A00, EA80, 7A00-7A0Z, EA90, 1F90, 3B64, FA20, 1F28-1G0Z, 3B10, 8A01, 8C70, BA00-BE2Z, 6D80-6D8Z, 5C80, DD72, DA63, BA40, 5C52-5C59, 8B11, DB61-GB90, 2B33, BA00, 2A90, 8B20, 4A40, 2A20, BD4Z, DD91, 5B50-5B71, 2C82, 1D6Y, 5C50-5D2Z, 2B91, 3A51, GB40, 2C90, DB96.2, GB61, 2C76.43, 2C73.4, XH3854, 1D48, FA0Z, 2C15, 2C12.01, 2B72.0, BC81.3, 2D60.0, 2A81, 2C90.Y, 9A78.50, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, 2C12.02, 2C25.Y, GA10.B4, 2B70, 2C94.2, 1D82, 4A40.0, 2D10.Z, 2C25.0, 2C76.Z, 2C27, 2C61, 2A00.00, XH6153, 2C80.2, 1D60.01, 2D11 |
| Family Name | Asteraceae |
| Family Tax Id | 4210 |
- 1. (1s,4as,7s,7as)-1-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-4-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxycarbonyl-1,4a,5,6,7,7a-Hexahydrocyclopenta[C]pyran-7-Carboxylic Acid (PubChem CID: 101673969)
- 2. (1s,4as,7s,7as)-7-Methoxycarbonyl-1-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-1,4a,5,6,7,7a-Hexahydrocyclopenta[C]pyran-4-Carboxylic Acid (PubChem CID: 101673972)
- 3. (3ar,5as,5br,7ar,9s,11ar,11br,13bs)-9-Hydroxy-2,2,5a,5b,8,8,11a-Heptamethyl-3,4,5,6,7,7a,9,10,11,11b,12,13b-Dodecahydro-1h-Cyclopenta[A]chrysene-3a-Carboxylic Acid (PubChem CID: 163053558)
- 4. 4-Hydroxyacetophenone (PubChem CID: 7469)
- 5. 5-O-Methylxanthone V1 (PubChem CID: 12178329)
- 6. 7-O-Methyl 4-O-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl] (1s,4as,7s,7as)-1-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-1,4a,5,6,7,7a-Hexahydrocyclopenta[C]pyran-4,7-Dicarboxylate (PubChem CID: 101673970)
- 7. [(2r,3r,4r,5r,6r)-6-[(2r)-2-(3,4-Dihydroxyphenyl)-2-Hydroxyethoxy]-5-Hydroxy-2-(Hydroxymethyl)-4-[(2r,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxyoxan-3-Yl] 3-(3,4-Dihydroxyphenyl)prop-2-Enoate (PubChem CID: 163000796)
- 8. [(2r,3r,4r,5r,6r)-6-[2-(3,4-Dihydroxyphenyl)ethoxy]-5-Hydroxy-2-(Hydroxymethyl)-4-[(2r,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxyoxan-3-Yl] 3-(3,4-Dihydroxyphenyl)prop-2-Enoate (PubChem CID: 162969710)
- 9. [(2r,3s,4r,5s,6s)-6-[2-(3,4-Dihydroxyphenyl)ethoxy]-5-Hydroxy-2-(Hydroxymethyl)-4-[(2s,3r,4r,5s,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxyoxan-3-Yl] (E)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate (PubChem CID: 162969698)
- 10. [(2s,3r,4s,5s,6r)-6-[2-(3,4-Dihydroxyphenyl)ethoxy]-5-Hydroxy-4-[(2s,3s,4s,5r,6r)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxy-2-[[(2s,3s,4r,5r)-3,4,5-Trihydroxyoxan-2-Yl]oxymethyl]oxan-3-Yl] (E)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate (PubChem CID: 163068794)
- 11. Adoxosidic Acid (PubChem CID: 13892717)
- 12. Aloenin (PubChem CID: 162305)
- 13. Arctigenin (PubChem CID: 64981)
- 14. Arctiin (PubChem CID: 100528)
- 15. Astragalin (PubChem CID: 5282102)
- 16. Beta-Sitosterol (PubChem CID: 222284)
- 17. Cudraxanthone G (PubChem CID: 42645953)
- 18. Dimethyl (1s,4as,7s,7as)-1-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-1,4a,5,6,7,7a-Hexahydrocyclopenta[C]pyran-4,7-Dicarboxylate (PubChem CID: 101673971)
- 19. Ethane (PubChem CID: 6324)
- 20. Euxanthone (PubChem CID: 5281631)
- 21. Forsythide (PubChem CID: 15559328)
- 22. Forsythoside F (PubChem CID: 6442994)
- 23. Forsythoside G (PubChem CID: 101231533)
- 24. Isoquercetin (PubChem CID: 5280804)
- 25. Matairesinoside (PubChem CID: 486612)
- 26. Nataloe-Emodin (PubChem CID: 12313148)
- 27. Oleyl Alcohol (PubChem CID: 5284499)
- 28. Rutin (PubChem CID: 5280805)
- 29. Trans,trans-1,3,11-Tridecatriene-5,7,9-Triyne (PubChem CID: 5322028)
- 30. Triacontane (PubChem CID: 12535)
- 31. Ursolic Acid (PubChem CID: 64945)
- 32. Verbascoside (PubChem CID: 5281800)
- 1. Alzheimer's Disease 1
- 2. Arthritis, Rheumatoid
- 3. Asthma
- 4. Cardiovascular Diseases
- 5. Cholera
- 6. Crohn Disease
- 7. Dementia
- 8. Diabetes Mellitus
- 9. Glaucoma
- 10. Lupus Erythematosus, Systemic
- 11. Muscular Dystrophies
- 12. Myocardial Infarction
- 13. Nephritis
- 14. Osteoarthritis
- 15. Pre-Eclampsia
- 16. Psoriasis
- 17. Thrombocytopenia
Not listed in any formulations.